Skip to main content

Clinical Data Mining to Discover Optimal Treatment Patterns

  • Chapter
  • First Online:
Systems Analysis Tools for Better Health Care Delivery

Part of the book series: Springer Optimization and Its Applications ((SOIA,volume 74))

Abstract

With more healthcare providers adopting an electronic medical record, with the ready availability of insurance claims data, and with the availability of government sponsored healthcare databases, it is possible to use data mining and analytic tools to investigate optimal treatment decisions in medical practice. In this chapter, we present several data mining tools that can be used to investigate health outcomes, and we then provide a sample analysis of healthcare data to demonstrate their use. The tools include market basket analysis, text analysis, and predictive modeling. We use these tools to investigate cancer treatments. The need to analyze real data is particularly necessary with the increased prominence of comparative effectiveness analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Cerrito, P.: Text mining techniques for healthcare provider quality determination: methods for rank comparisons. IGI Publishing, Hershey, PA (2009)

    Book  Google Scholar 

  2. Cerrito, P.: Clinical trials versus health outcomes research: SAS/STAT versus SAS enterprise miner. Paper presented at the PharmaSug, Nashville, TN (2011)

    Google Scholar 

  3. Devlin, K.: NHS patients denied drugs due to lack of common sense at NICE, say charities. Telegraph. Retrieved from http://www.telegraph.co.uk/health/healthnews/3531280/NHS-patients-denied-drugs-due-to-lack-of-common-sense-at-Nice-say-charities.html (2008)

  4. Mason, A.R., Drummond, M.F.: Public funding of new cancer drugs: is NICE getting nastier? Eur. J. Canc. 45, 1188–1192 (2009)

    Article  Google Scholar 

  5. Bruno, M.-A., Bernheim, J.L., ledoux, D., Pellas, F., Demertzi, A., Laureys, S.: A survey on self-assessed well-being in a cohort of chronic locked-in syndrome patients: happy majority, miserable minority. BMJ Open. Retrieved from http://bmjopen.bmj.com/content/early/2011/02/16/bmjopen-2010-000039.full (2011)

  6. Anonymous-WSJ. The Avastin Mugging: The FDA rigs the verdict against a good cancer. Wall St. J. Retrieved from http://online.wsj.com/article/SB10001424052748704271804575405203894857436.html (2010)

  7. Perrone, M.: FDA delays decision on breast cancer drug Avastin. AP Associated Press. Retrieved from http://www.msnbc.msn.com/id/39239537/ns/health-cancer/ (2010)

  8. Anonymous-maintenance study. Bevacizumab and combination chemotherapy in treating patients with previously untreated metastatic colorectal cancer that cannot be removed by surgery. (NCt00797485). Retrieved from http://clinicaltrials.gov/ct2/show/NCT00797485 (2009)

  9. Anonymous-bevacizumab. Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. National Health Service, London (2009)

    Google Scholar 

  10. Giuliani, F., Vita, F.D., Colucci, G., Pisconti, S.: Maintenance therapy in colon cancer. Canc. Treat. Rev. 26(Suppl 3), S42–45 (2010)

    Article  Google Scholar 

  11. Hay, J.W.: Using pharmacoeconomics to value pharmacotherapy. Clin. Pharmacol. Therapeut. 84(2), 197–200 (2008)

    Article  Google Scholar 

  12. Puthillath, A., Patel, A., Fakih, M.G.: Targeted therapies in the management of colorectal carcinoma: role of bevacizumab. Onco. Targets Ther. 2, 1–15 (2009)

    Google Scholar 

  13. Castells, M.C., Tennant, N.M., Sloane, D.E., Hsu, F.I., Barrett, N.A., Hong, D.I., et al.: Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J. Allergy Clin. Immunol. 122, 574–580 (2008)

    Article  Google Scholar 

  14. Togashi, Y., Kim, Y.H., Masago, K., Tamai, K., Sakamori, Y., Mio, T., et al.: Pulmonary embolism due to internal jugular vein thrombosis in a patient with non-small cell lung cancer receiving bevacizumab Retrieved from http://www.springerlink.com/content/0208402248n7mn4k/ (2010)

Download references

Acknowledgment

The author wishes to acknowledge the support of Dr. John Cerrito, PharmD, concerning the nature and effects of the drugs discussed in this chapter.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cerrito, P. (2013). Clinical Data Mining to Discover Optimal Treatment Patterns. In: Pardalos, P., Georgiev, P., Papajorgji, P., Neugaard, B. (eds) Systems Analysis Tools for Better Health Care Delivery. Springer Optimization and Its Applications, vol 74. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5094-8_6

Download citation

Publish with us

Policies and ethics